Miles, J., & White, Y. (2018). Neratinib for the Treatment of Early-Stage HER2-Positive Breast Cancer. J Adv Pract Oncol.
Citação norma ChicagoMiles, Jennifer, and Yahsin White. "Neratinib for the Treatment of Early-Stage HER2-Positive Breast Cancer." J Adv Pract Oncol 2018.
Citação norma MLAMiles, Jennifer, and Yahsin White. "Neratinib for the Treatment of Early-Stage HER2-Positive Breast Cancer." J Adv Pract Oncol 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.